Device Trial Radar · NCT06571370
Wave Crossover ECP Study for Simplified Therapy
Last checked: Nov 19, 2026Latest source record: Apr 7, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
52
Actual
Start
Sep 26, 2024
Primary completion
Feb 4, 2025
Study completion Feb 4, 2025
Sponsor
- Lead sponsor
- PressionNot on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 26, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 35 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to demonstrate substantial equivalence between Pression's Wave PRO System and a commercially available predicate ECP device to support a U.S. 510(k) submission for the Wave PRO System.
Conditions
- Chronic Stable Angina
- Refractory Angina
Interventions
External CounterpulsationDevice
Cardiac gated, lower limb compression
Primary outcomes
What the sponsor says the trial is designed to measure.
- Diastolic AugmentationTime frame: During treatment, measured at the 8th minute of compressions
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Monroe Biomedical Research
Monroe, North Carolina
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.